- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06806007
Incentive Spirometer Training and Oropharyngeal Motor Training for Pulmonary Dysfunction in Spastic Diplegic Children
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
This is a prospective randomized controlled clinical trial, conducted at Kafr El sheikh Hospital.
- Forty-eight children of both genders.
- The study will include children (age 3-7 years) post selective pulmonary dysfunction.
- Children meeting the inclusion criteria will be randomly assigned to one of three groups:
- first Experimental Group: children in this group will receive incentive spirometer training.
- second Experimental Group:children in this group will receive oropharyngeal motor training. .
- third experimental Group: Patients in this group will receive combination of incentive spirometer training and oropharyngeal motor training
- Randomization will be achieved using computer-generated random numbers to ensure an equal distribution of patients between the two groups.
Conditions: Cerebral Palsy
Study Type
Enrollment (Estimated)
Phase
- Early Phase 1
Contacts and Locations
Study Locations
-
-
-
Kafrelsheikh, Egypt
- Faculty of physical therapy Kafrelsheikh university
-
-
KafrelsheikhU
-
Kafrelsheikh, KafrelsheikhU, Egypt
- Faculty of physical therapy Kafrelsheikh university
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- the children with spastic CP between the age from 3 to 7 years old.
Level I to IV on the gross motor function classification system (GMFCS) , who have the partial ability to maintain antigravity head and trunk postures.
- Cognitive and cooperative function allowing pulmonary function measurements.
- No history of psychiatric or neurological disorders rather than cp.
Exclusion Criteria:
- Any uncontrolled clinically significant medical conditions such as coexistent cardiac disease or respiratory disease
- Children with cognitive impairment who are unable to comply with the protocol required procedure
- Children who are taking medications that can affect respiratory function
- Children with presence or history of tracheostomy
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Group A : Will include 16 spastic diplegic Children suffer from pulmonary dysfunction from both gend
Each child in the group A will receive the incentive spirometer training , attending three sessions per week for three consecutive months. The duration of the session will be half an hour Set up
|
Each child in the group A will receive the incentive spirometer training , attending three sessions per week for three consecutive months. The duration of the session will be half an hour Set up
|
|
Experimental: Group B :Will include 16 spastic diplegic Children suffer from pulmonary dysfunction from both gende
Each child in the group B will receive the oropharyngeal motor training programme , attending three sessions per week for three consecutive months. The duration of the session will be an hour The training programme consists of 10 individual mobilization exercises involving orofacial and pharyngeal area that required 45 minutes Each exercise had to be repeated for 10 times. The 10 exercises are:
|
Each child in the group B will receive the oropharyngeal motor training programme , attending three sessions per week for three consecutive months. The duration of the session will be an hour The training programme consisted of 10 individual mobilization exercises involving orofacial and pharyngeal area that required 45 minutes Each exercise had to be repeated for 10 times. The 10 exercises are:
|
|
Experimental: Group C : Will include 16 spastic diplegic Children suffer from pulmonary dysfunction from both gend
Each child in the group C will receive a combination program of the incentive spirometer training and oropharyngeal motor training programme attending three sessions per week for three consecutive months.
The duration of the session will be one hour and half that Will be designed into half an hour for the incentive spirometer training and an hour for the oropharyngeal motor training programme
|
Each child in the group C will receive a combination program of the incentive spirometer training and oropharyngeal motor training programme attending three sessions per week for three consecutive months.
The duration of the session will be one hour and half that Will be designed into half an hour for the incentive spirometer training and an hour for the oropharyngeal motor training programme
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
forced vital capacity (FVC)
Time Frame: Two months
|
1) By using digital incentive spirometry which is the amount of air that an individual is able to forcibly exhale from his / her lungs after taking the deepest breath they can.
|
Two months
|
|
forced expiratory volume at 1 s (FEV1)
Time Frame: Two months
|
1) By using digital incentive spirometry refers to the air an individual can exhale during a forced breath in 1 second
|
Two months
|
|
FVC/FEV1 ratio
Time Frame: Two months
|
1) By using digital incentive spirometry refers to the air an individual can exhale during a forced breath in 1 second
|
Two months
|
|
expiratory reserve volume (ERV)
Time Frame: Two months
|
1) By using digital incentive spirometry the amount of extra air above normal that you exhale during a forceful breath out.
|
Two months
|
|
Peak expiratory flow (PEF)
Time Frame: Two months
|
the volume of air forcefully expelled from the lungs in one quick exhalation
|
Two months
|
|
forced expiratory flow (FEF)
Time Frame: Two months
|
the speed that someone can breathe out air from their lungs, measured in the middle of a hard, fast breath out.
|
Two months
|
|
tidal volume (TV)
Time Frame: Two months
|
refers to the air an individual can exhale during a forced breath in 1 second
|
Two months
|
|
inspiratory reserve volume (IRV)
Time Frame: Two months
|
the additional volume of air that can be inspired at the end of a normal or tidal inspiration
|
Two months
|
|
the orofacial myofunctional clinical evaluation
Time Frame: Two months
|
the OMES protocol is an instrument for the clinical evaluation of orofacial structures and functions of children that will permit the examiner to express numerically his perception of the characteristics and behaviors observed, and that can be administered without special equipment and in a brief manner
|
Two months
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- KFSIRB200-342
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Pulmonary Dysfunction
-
Johann Wolfgang Goethe University HospitalCompletedPostoperative Pulmonary DysfunctionGermany
-
University Children's Hospital BaselRecruitingPulmonary DysfunctionSwitzerland
-
Assiut UniversityActive, not recruiting
-
Assiut UniversityNot yet recruiting
-
University Hospital, EssenCompletedHeart Failure | Pulmonary Hypertension | Ventricular Dysfunction | Ventricular Dysfunction, LeftGermany
-
University of WashingtonNational Heart, Lung, and Blood Institute (NHLBI)RecruitingPulmonary Arterial Hypertension | Right Ventricular Dysfunction | Right Heart Failure | Pulmonary Vascular DisorderUnited States
-
University Hospital, AngersNot yet recruiting
-
GE HealthcareOregon Health and Science UniversityCompletedHeart Valve Diseases | Pulmonary Hypertension | Right Ventricular Dysfunction | Left Ventricular DysfunctionUnited States
-
University of California, San FranciscoRecruitingRight Ventricular Dysfunction | Pulmonary Artery HypertensionUnited States
-
Northwell HealthActive, not recruitingThromboembolism | Pulmonary Hypertension | Pulmonary Embolism | Right Ventricular DysfunctionUnited States
Clinical Trials on Group A
-
Hongxia WangRecruiting
-
Fayoum UniversityNot yet recruitingZygomatic ImplantsEgypt
-
BioSyngen Pte LtdSouth China Hospital of Shenzhen UniversityNot yet recruiting
-
Chung Shan Medical UniversityCompleted
-
The University of Texas Health Science Center,...National Institute for Occupational Safety and Health (NIOSH/CDC)Completed
-
Kahramanmaras Sutcu Imam UniversityCompletedPain | Interleukin | Vessels; VaricoseTurkey
-
Manuel RodríguezUnknownBrain IschemiaSpain
-
Riphah International UniversityCompletedAutism Spectrum DisorderPakistan
-
BioSyngen Pte LtdSouth China Hospital of Shenzhen UniversityNot yet recruitingColorectal Cancer | Pancreatic Cancer
-
Dr. Jean-Sebastien Delisle, MD, PhDCompletedLymphoma | Epstein-Barr Virus Infections | Post-Transplant Lymphoproliferative DisorderCanada